Cite
Cost-Effectiveness of Asthma Step-Up Therapy as an Increased Dose of Extrafine-Particle Inhaled Corticosteroid or Add-On Long-Acting Beta-Agonist.
MLA
Roche, Nicolas, et al. “Cost-Effectiveness of Asthma Step-Up Therapy as an Increased Dose of Extrafine-Particle Inhaled Corticosteroid or Add-On Long-Acting Beta-Agonist.” Pulmonary Therapy, vol. 2, no. 1, June 2016, pp. 73–89. EBSCOhost, https://doi.org/10.1007/s41030-016-0014-2.
APA
Roche, N., Colice, G., Israel, E., Martin, R., Dorinsky, P., Postma, D., Guilbert, T., Grigg, J., Aalderen, W., Barion, F., Hillyer, E., Thomas, V., Burden, A., Brett McQueen, R., & Price, D. (2016). Cost-Effectiveness of Asthma Step-Up Therapy as an Increased Dose of Extrafine-Particle Inhaled Corticosteroid or Add-On Long-Acting Beta-Agonist. Pulmonary Therapy, 2(1), 73–89. https://doi.org/10.1007/s41030-016-0014-2
Chicago
Roche, Nicolas, Gene Colice, Elliot Israel, Richard Martin, Paul Dorinsky, Dirkje Postma, Theresa Guilbert, et al. 2016. “Cost-Effectiveness of Asthma Step-Up Therapy as an Increased Dose of Extrafine-Particle Inhaled Corticosteroid or Add-On Long-Acting Beta-Agonist.” Pulmonary Therapy 2 (1): 73–89. doi:10.1007/s41030-016-0014-2.